Related Experiment Video
Updated: Sep 11, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Glycaemic control in labour with diabetes: GILD, a scoping study
Nia Wyn Jones1, Eleanor J Mitchell1,2, Kate F Walker1
1Centre for Perinatal Research, School of Medicine, University of Nottingham, Nottingham, UK.
A new study designed a feasible clinical trial to compare permissive versus intensive glucose control during labour for pregnant women with diabetes. This approach is acceptable to patients and healthcare professionals, paving the way for future research.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Clinical Trial Design
Background:
- Diabetes in pregnancy affects 5-10% of pregnancies.
- Poor intrapartum glycemic control is linked to adverse neonatal outcomes.
- Current tight glucose control is burdensome and may not always be necessary.
Purpose of the Study:
- To assess the feasibility of a randomized clinical trial.
- To compare permissive versus intensive intrapartum glycemic control in pregnancies with diabetes.
- To evaluate clinical and cost-effectiveness.
Main Methods:
- Mixed-methods study including guideline audits, surveys, and service evaluation.
- Development of a non-inferiority umbrella trial protocol.
- Qualitative interviews to assess trial acceptability.
Main Results:
- Significant variation exists in current clinical practices for intrapartum glucose management.
- 66% of surveyed women expressed willingness to participate in a future trial.
- A feasible and acceptable umbrella trial design was developed.
Conclusions:
- An umbrella trial comparing permissive and intensive glycemic control is feasible and acceptable.
- This approach addresses the need for optimal intrapartum glucose management in diabetic pregnancies.
- Further research is recommended with an internal pilot phase.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
08:01A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
Published on: August 12, 2016
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications